Revenues of Tengjun Biotechnology Corp. from 31 Dec 2020 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Tengjun Biotechnology Corp. quarterly and annual Revenues in USD history and change rate from 31 Dec 2020 to 31 Mar 2023.
  • Tengjun Biotechnology Corp. Revenues for the quarter ending 31 Mar 2023 was $8,516,646, a 99% increase year-over-year.
  • Tengjun Biotechnology Corp. Revenues for the twelve months ending 31 Mar 2023 was $154,369,270.
  • Tengjun Biotechnology Corp. annual Revenues for 2022 was $150,136,738.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)

Tengjun Biotechnology Corp. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $154,369,270 $8,516,646 +$4,232,532 +99% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $150,136,738 $58,144,058 01 Oct 2022 31 Dec 2022 10-K 17 Apr 2023 2022 FY
Q3 2022 $36,418,104 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $51,290,462 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2023 2023 Q2
Q1 2022 $4,284,114 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1

Tengjun Biotechnology Corp. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $150,136,738 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023 2022 FY
2020 $290* 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.